Positions

Selected Publications

Academic Article

Year Title Altmetric
2019 Longitudinal assessment of anchored transponder migration following lung stereotactic body radiation therapy.Journal of Applied Clinical Medical Physics.  20:17-22. 2019
2019 Prostate Stereotactic Body Radiation Therapy With a Focal Simultaneous Integrated Boost: Acute Toxicity and Dosimetry Results From a Prospective Trial.Advances in Radiation Oncology.  4:90-95. 2019
2018 NCCN Guidelines Insights: Small Cell Lung Cancer, Version 2.2018.Journal of the National Comprehensive Cancer Network.  16:1171-1182. 2018
2018 NCCN guidelines® insights non–small cell lung cancer, version 5.2018 featured updates to the NCCN guidelinesJournal of the National Comprehensive Cancer Network.  16:807-821. 2018
2018 Safety and Outcome Measures of First-in-Human Intraperitoneal α Radioimmunotherapy With 212Pb-TCMC-Trastuzumab.American Journal of Clinical Oncology.  41:716-721. 2018
2018 Stereotactic Radiosurgery for Prostate Cancer Following Magnetic Resonance Imaging Directed Biopsy: A Multidisciplinary Approach with Case Examples.Cureus.  10:e2524. 2018
2017 Non-Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology.Journal of the National Comprehensive Cancer Network.  15:504-535. 2017
2017 Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial.Journal of Clinical Oncology.  35:56-62. 2017
2017 Subcutaneous adipose tissue characteristics and the risk of biochemical recurrence in men with high-risk prostate cancer.Urologic Oncology: Seminars and Original Investigations.  35:663.e15-663.e21. 2017
2016 Analysis of Predictive Factors for Acute Esophagitis in Lung Cancer Radiation Therapy.International Journal of Radiation Oncology - Biology - Physics.  96:E193-E194. 2016
2016 Analysis of Predictive Factors for Pneumonitis in Lung Cancer Radiation Therapy.International Journal of Radiation Oncology - Biology - Physics.  96:E482-E483. 2016
2016 NCCN Guidelines Insights: Malignant Pleural Mesothelioma, Version 3.2016.Journal of the National Comprehensive Cancer Network.  14:825-836. 2016
2016 NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 4.2016.Journal of the National Comprehensive Cancer Network.  14:255-264. 2016
2016 Correction: Kinomic Profiling of Electromagnetic Navigational Bronchoscopy Specimens: A New Approach for Personalized Medicine.PLoS ONE.  11:e0161986. 2016
2016 Long-Term Outcomes Among Patients Who Achieve Complete or Near-Complete Responses After the Induction Phase of Bladder-Preserving Combined-Modality Therapy for Muscle-Invasive Bladder Cancer: A Pooled Analysis of NRG Oncology/RTOG 9906 and 0233.International Journal of Radiation Oncology - Biology - Physics.  94:67-74. 2016
2015 A Phase 3 Trial of 2 Years of Androgen Suppression and Radiation Therapy With or Without Adjuvant Chemotherapy for High-Risk Prostate Cancer: Final Results of Radiation Therapy Oncology Group Phase 3 Randomized Trial NRG Oncology RTOG 9902.International Journal of Radiation Oncology - Biology - Physics.  93:294-302. 2015
2015 Retention Rate of Electromagnetic Navigation Bronchoscopic Placed Fiducial Markers for Lung Radiosurgery.Annals of Thoracic Surgery.  100:1163-1165. 2015
2015 Non-Small Cell Lung Cancer, Version 6.2015.Journal of the National Comprehensive Cancer Network.  13:515-524. 2015
2015 Non-Small cell lung cancer, version 6.2015: Featured updates to the NCCN guidelinesJournal of the National Comprehensive Cancer Network.  13:515-524. 2015
2015 Continuous chemoradiation following complete response to neo-adjuvant chemotherapy provides improved outcomes in muscle invasive urothelial carcinomaJournal of Solid Tumors.  5:59-68. 2015
2014 Comparison of plan quality and delivery time between volumetric arc therapy (RapidArc) and Gamma Knife radiosurgery for multiple cranial metastases.Neurosurgery.  75:409-417. 2014
2014 PSA response to neoadjuvant androgen deprivation is an independent prognostic marker and may identify patients who benefit from treatment escalation.Urologic Oncology: Seminars and Original Investigations.  32:687-693. 2014
2014 Patterns of failure for glioblastoma multiforme following limited-margin radiation and concurrent temozolomide.Radiation Oncology.  9:130. 2014
2014 Kinomic profiling of electromagnetic navigational bronchoscopy specimens: a new approach for personalized medicine.PLoS ONE.  9:e116388. 2014
2013 Stereotactic body radiation therapy (SBRT) for lung malignancies: preliminary toxicity results using a flattening filter-free linear accelerator operating at 2400 monitor units per minute.Radiation Oncology.  8:273. 2013
2013 Effects of flattening filter-free and volumetric-modulated arc therapy delivery on treatment efficiency.Journal of Applied Clinical Medical Physics.  14:4328. 2013
2013 Efficacy and toxicity of conventionally fractionated pelvic radiation with a hypofractionated simultaneous versus conventionally fractionated sequential boost for patients with high-risk prostate cancer.Acta Oncologica.  52:1181-1188. 2013
2013 Flattening filter-free linac improves treatment delivery efficiency in stereotactic body radiation therapy.Journal of Applied Clinical Medical Physics.  14:4126. 2013
2013 Patient benefit from salvage radiation for prostate cancer.Journal of Clinical Oncology.  31:175. 2013
2013 Effects of flattening filter-free and volumetric-modulated arc therapy delivery on treatment efficiencyJournal of Applied Clinical Medical Physics.  14:155-166. 2013
2013 Flattening filter-free linac improves treatment delivery efficiency in stereotactic body radiation therapyJournal of Applied Clinical Medical Physics.  14:64-71. 2013
2013 Optimal planning target volume margins for elective pelvic lymphatic radiotherapy in high-risk prostate cancer patients.ISRN Oncology.  2013:941269. 2013
2012 Hypofractionated Prostate Radiotherapy with or without Conventionally Fractionated Nodal Irradiation: Clinical Toxicity Observations and Retrospective Daily Dosimetry.Prostate Cancer.  2012:546794. 2012
2011 Treatment of small cell lung cancer with TRA-8 in combination with cisplatin and radiation.Radiotherapy and Oncology.  101:183-189. 2011
2011 Efficacy and rectal toxicity of hypofractionated radiation therapy with daily image guidance.Journal of Clinical Oncology.  29:85. 2011
2011 Dosimetric analysis of imaging changes following pulmonary stereotactic body radiation therapy.Australasian Radiology.  55:90-96. 2011
2011 Patterns of failure for glioblastoma multiforme following concurrent radiation and temozolomide.Australasian Radiology.  55:77-81. 2011
2011 Cetuximab augments cytotoxicity with poly (adp-ribose) polymerase inhibition in head and neck cancer.PLoS ONE.  6:e24148. 2011
2010 Margin on gross tumor volume and risk of local recurrence in head-and-neck cancer.International Journal of Radiation Oncology - Biology - Physics.  76:164-168. 2010
2009 Cancer of the tonsil presenting as central nervous system metastasis: A case report.Head & neck surgery.  31:127-130. 2009
2006 Epidermal growth factor receptor tyrosine kinase inhibitor, erlotinib, and concurrent 5-fluorouracil, cisplatin and radiotherapy for patients with esophageal cancer: a phase I study.Anti-Cancer Drugs.  17:95-102. 2006

Education And Training

  • Doctor of Medicine, Medical College of Ohio
  • Full Name

  • Michael Dobelbower